Quarterly report · Q3
7459.TEDINET S100Q61E
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.57T | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥3.29T | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.51T | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥37.5bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥37.0bn | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥49.9bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥62.0bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥51.8bn | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥56.7bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥52.2bn | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥29.8bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥29.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥28.8bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥37.1bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥36.7bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥1.81T | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥1.71T | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥1.78T | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.13T | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥1.06T | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥678.0bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥649.1bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥649.5bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥252.0bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥243.2bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥142.16 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.65 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥140.14 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥137.32 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥49.09 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥136.4 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥131.41 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥128.87 | 2021-04-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 30.6% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.0% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.9% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥7.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥7.0bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | ¥44m |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥56.2bn |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥56.2bn |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥2m |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.2bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥848.2bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥847.9bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥253m |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥19.1bn |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.67T |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.66T |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥6.7bn |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥16.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥2.57T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥2.57T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥37.5bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | −¥2.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-12-31 | −¥2.8bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | ¥391m |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥54.8bn |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥54.8bn |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥2m |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥2.2bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥802.1bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥801.8bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥260m |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥20.2bn |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥1.65T |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥1.65T |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥2.6bn |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥14.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-12-31 | ¥2.51T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-12-31 | ¥2.51T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥2.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-12-31 | ¥36.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 384
| Item | Context | Value | Unit |
|---|---|---|---|
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 8120000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 1650631000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E02632-000CosmeticsDailyNecessitiesReportableSegmentsMember | 801842000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleBusinessReportableSegmentsMember | 54797000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 2507270000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | Prior1YTDDuration | 2507270000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 2571000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E02632-000CosmeticsDailyNecessitiesReportableSegmentsMember | 260000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleBusinessReportableSegmentsMember | 2000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 2834000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -2834000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | - | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 1653202000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E02632-000CosmeticsDailyNecessitiesReportableSegmentsMember | 802102000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleBusinessReportableSegmentsMember | 54799000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 2510104000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -2834000000 | JPY |
| Net sales | Prior1YTDDuration | 2507270000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 14219000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E02632-000CosmeticsDailyNecessitiesReportableSegmentsMember | 20232000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleBusinessReportableSegmentsMember | 2188000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 36639000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | 391000000 | JPY |
| Operating income | Prior1YTDDuration | 37031000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 1663237000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02632-000CosmeticsDailyNecessitiesReportableSegmentsMember | 847942000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleBusinessReportableSegmentsMember | 56238000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 2567418000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | CurrentYTDDuration | 2567418000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 6695000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E02632-000CosmeticsDailyNecessitiesReportableSegmentsMember | 253000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleBusinessReportableSegmentsMember | 2000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 6951000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -6951000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | - | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 1669933000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E02632-000CosmeticsDailyNecessitiesReportableSegmentsMember | 848195000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleBusinessReportableSegmentsMember | 56240000000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 2574369000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -6951000000 | JPY |
| Net sales | CurrentYTDDuration | 2567418000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 16219000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02632-000CosmeticsDailyNecessitiesReportableSegmentsMember | 19110000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleBusinessReportableSegmentsMember | 2157000000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 37487000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | 44000000 | JPY |
| Operating income | CurrentYTDDuration | 37531000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |